This map shows the geographic impact of L Bertilsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Bertilsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Bertilsson more than expected).
This network shows the impact of papers produced by L Bertilsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Bertilsson. The network helps show where L Bertilsson may publish in the future.
Co-authorship network of co-authors of L Bertilsson
This figure shows the co-authorship network connecting the top 25 collaborators of L Bertilsson.
A scholar is included among the top collaborators of L Bertilsson based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with L Bertilsson. L Bertilsson is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Askling, Johan, Michael Fored, Lena Brandt, et al.. (2006). TNF-antagonist treatment and risk of hospitalisation for cardiovascular disease. Results from the National Swedish Monitoring-Program for Biologies in Ra (ARTIS).. Arthritis & Rheumatism. 54.
6.
Askling, Johan, Michael Fored, Lena Brandt, et al.. (2006). TNF-antagonist treatment and risk of hospitalisation for infection. Results from the National Swedish Monitoring-Program for Biologics in RA (ARTIS).. Arthritis & Rheumatism. 54.1 indexed citations
7.
Askling, Johan, C. Michael Fored, Lena Brandt, et al.. (2005). Risk of tuberculosis in rheumatoid arthritis and following anti-TNF treatment. Preliminary results of an ongoing Swedish monitoring-programme of biologics in RA. Annals of the Rheumatic Diseases. 64.3 indexed citations
8.
Askling, Johan, C. Michael Fored, Lena Brandt, et al.. (2005). Risk of cardiovascular morbidity and mortality following TNF-blockade. Preliminary results of an ongoing Swedish monitoring-programme of biologics in RA. Annals of the Rheumatic Diseases. 64. 448–449.2 indexed citations
Feltelius, Nils, Michael Fored, Peter Blomqvist, et al.. (2004). Safety and efficacy of adalimumab in arthritis patients previously treated with another biologic agent. Annals of the Rheumatic Diseases. 63.2 indexed citations
11.
Brandt, Lena, L Bertilsson, Nils Feltelius, et al.. (2004). A national database for co-morbidity in RA to evaluate drug safety. Solid cancers in RA and following anti-TNF treatment. Annals of the Rheumatic Diseases. 63.
12.
Askling, Johan, Lena Brandt, L Bertilsson, et al.. (2004). Risk for lymphomas following TNF-blockade. Comparisons with a nationwide co-morbidity database. Annals of the Rheumatic Diseases. 63.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.